[13C6]-Tranexamic acid hydrochloride

[13C6]-Tranexamic acid hydrochloride, also known as [13C6]-TXA, is a stable-isotope labeled form of the antifibrinolytic drug tranexamic acid. This molecule has six carbon atoms that are labeled with the stable isotope, carbon-13. This labeling allows for the use of mass spectrometry techniques to track the metabolism and distribution of the drug within the body. Tranexamic acid is primarily used to prevent and treat excessive bleeding during surgical procedures or in patients with bleeding disorders. It works by inhibiting the breakdown of blood clots, which can help to prevent excessive bleeding. [13C6]-Tranexamic acid hydrochloride is used in research studies to investigate the pharmacokinetics and pharmacodynamics of the drug. It is also used in clinical trials to understand the metabolism and distribution of the drug in patients. The chemical formula of [13C6]-Tranexamic acid hydrochloride is C13H17ClN2O2, and it has a molecular weight of 290.74 g/mol. The drug is soluble in water and has a melting point of 223-225°C. It is typically administered intravenously or orally, and the dosage and administration schedule can vary depending on the patient's condition. In summary, [13C6]-Tranexamic acid hydrochloride is a stable isotope-labeled form of the antifibrinolytic drug tranexamic acid. Its use in research studies and clinical trials allows for a better understanding of the pharmacokinetics and pharmacodynamics of the drug.